相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data
Basil Donovan et al.
LANCET INFECTIOUS DISEASES (2011)
Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia
S. Daayana et al.
BRITISH JOURNAL OF CANCER (2010)
Incidence, Duration, and Reappearance of Type-Specific Cervical Human Papillomavirus Infections in Young Women
Ralph P. Insinga et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Expression of human papillomavirus type 16 E7 oncoprotein alters keratinocytes expression profile in response to tumor necrosis factor-α
Enrique Boccardo et al.
CARCINOGENESIS (2010)
Multiplexed Serologic Assay for Nine Anogenital Human Papillomavirus Types
David Opalka et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
HPV-Mediated Genome Instability: At the Roots of Cervical Carcinogenesis
E. Boccardo
CYTOGENETIC AND GENOME RESEARCH (2010)
IL-1 signalling determines the fate of skin grafts expressing non-self protein in keratinocytes
Usriansyah Hadis et al.
EXPERIMENTAL DERMATOLOGY (2010)
Serological response to an HPV16 E7 based therapeutic vaccine in women with high-grade cervical dysplasia
Koenraad Van Doorslaer et al.
GYNECOLOGIC ONCOLOGY (2010)
Current understanding of the mechanism of HPV infection
John T. Schiller et al.
GYNECOLOGIC ONCOLOGY (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Genotype-Specific Clearance of Genital Human Papillomavirus (HPV) Infections among Mothers in the Finnish Family HPV Study
Karolina Louvanto et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells
Sandrine Henri et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Validation of multiplexed human papillomavirus serology using pseudovirions bound to heparin-coated beads
Helena Faust et al.
JOURNAL OF GENERAL VIROLOGY (2010)
Binding and neutralization characteristics of a panel of monoclonal antibodies to human papillomavirus 58
Sarah A. Brendle et al.
JOURNAL OF GENERAL VIROLOGY (2010)
Invariant NKT Cells in Hyperplastic Skin Induce a Local Immune Suppressive Environment by IFN-γ Production
Stephen R. Mattarollo et al.
JOURNAL OF IMMUNOLOGY (2010)
Antigen-Specific CD4 Cells Assist CD8 T-Effector Cells in Eliminating Keratinocytes
Jennifer K. Broom et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Longitudinal Study of Human Papillomavirus Persistence and Cervical Intraepithelial Neoplasia Grade 2/3: Critical Role of Duration of Infection
Ana Cecilia Rodriguez et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and -18 Infections
Mahboobeh Safaeian et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
K. Kian Ang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Common Genetic Variants and Risk for HPV Persistence and Progression to Cervical Cancer
Sophia S. Wang et al.
PLOS ONE (2010)
Skin Vaccination against Cervical Cancer Associated Human Papillomavirus with a Novel Micro-Projection Array in a Mouse Model
Holly J. Corbett et al.
PLOS ONE (2010)
Natural seroconversion to high-risk human papillomaviruses (hrHPVs) is not protective against related HPV genotypes
Johanna Palmroth et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2010)
Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection
Subhashini Jagu et al.
VACCINE (2010)
Immunogenic display of diverse peptides, including a broadly cross-type neutralizing human papillomavirus L2 epitope, on virus-like particles of the RNA bacteriophage PP7
Jerri do Carmo Caldeira et al.
VACCINE (2010)
Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments
Hans-Ulrich Bernard et al.
VIROLOGY (2010)
Mechanisms of cell entry by human papillomaviruses: an overview
Caroline A. J. Horvath et al.
VIROLOGY JOURNAL (2010)
The frequency of human papillomavirus findings in normal oral mucosa of healthy people by PCR
David Esquenazi et al.
BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY (2010)
Viral-Associated Nonmelanoma Skin Cancers: A Review
Meghan Dubina et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2009)
Human Papillomavirus Cofactors by Disease Progression and Human Papillomavirus Types in the Study to Understand Cervical Cancer Early Endpoints and Determinants
Sophia S. Wang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions
Susanne K. Kjaer et al.
CANCER PREVENTION RESEARCH (2009)
A Phase I Trial of a Human Papillomavirus DNA Vaccine for HPV16+ Cervical Intraepithelial Neoplasia 2/3
Cornelia L. Trimble et al.
CLINICAL CANCER RESEARCH (2009)
The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-γ production
Elvire Bourgeois et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
The role of furin in papillomavirus infection
Patricia M. Day et al.
FUTURE MICROBIOLOGY (2009)
Long-term persistence of anti-HPV-16 and-18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: Modeling of sustained antibody responses
Marie-Pierre David et al.
GYNECOLOGIC ONCOLOGY (2009)
Development of an HPV vaccine for a broad spectrum of high-risk types
Tadahito Kanda et al.
HUMAN VACCINES (2009)
Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection
Sven-Eric Olsson et al.
HUMAN VACCINES (2009)
Comparison of the immunogenicity and safety of Cervarix™ and Gardasil® human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years
Mark H. Einstein et al.
HUMAN VACCINES (2009)
Cancer incidence and risk factors after solid organ transplantation
Claire M. Vajdic et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
IFN-γ Promotes Generation of IL-10 Secreting CD4+ T Cells that Suppress Generation of CD8 Responses in an Antigen-Experienced Host
Xiao Song Liu et al.
JOURNAL OF IMMUNOLOGY (2009)
Common Variants in Immune and DNA Repair Genes and Risk for Human Papillomavirus Persistence and Progression to Cervical Cancer
Sophia S. Wang et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV-Naive Women Aged 16-26 Years
Darron R. Brown et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Hear All About It: Nightly Television News Coverage of Cervical Cancer Vaccination in the United States
Lorraine S. Wallace et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2009)
Role of Heparan Sulfate in Attachment to and Infection of the Murine Female Genital Tract by Human Papillomavirus
Katherine M. Johnson et al.
JOURNAL OF VIROLOGY (2009)
Intrafamilial Transmission and Family-Specific Spectra of Cutaneous Betapapillomaviruses
S. J. Weissenborn et al.
JOURNAL OF VIROLOGY (2009)
Human Papillomavirus Type 16 (HPV-16) Virus-Like Particle L1-Specific CD8+ Cytotoxic T Lymphocytes (CTLs) Are Equally Effective as E7-Specific CD8+ CTLs in Killing Autologous HPV-16-Positive Tumor Cells in Cervical Cancer Patients: Implications for L1 Dendritic Cell-Based Therapeutic Vaccines
Stefania Bellone et al.
JOURNAL OF VIROLOGY (2009)
Chimeric L1-L2 Virus-Like Particles as Potential Broad-Spectrum Human Papillomavirus Vaccines
Christina Schellenbacher et al.
JOURNAL OF VIROLOGY (2009)
Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia.
Gemma G. Kenter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding
Rhonda C. Kines et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women
C. K. Fairley et al.
SEXUALLY TRANSMITTED INFECTIONS (2009)
Efficacy, duration of immunity and cross protection after HPV vaccination: A review of the evidence
Paolo Bonanni et al.
VACCINE (2009)
Safety of human papillomavirus (HPV) vaccines: A review of the international experience so far
Theodoros Agorastos et al.
VACCINE (2009)
Longer term efficacy of a prophylactic monovalent human papillomavirus type 16 vaccine
Ali Rowhani-Rahbar et al.
VACCINE (2009)
The first clinical use of a live-attenuated Listeria monocytogenes vaccine: A Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix
Paulo Cesar Maciag et al.
VACCINE (2009)
Anaphylaxis following quadrivalent human papillomavirus vaccination
Julia M. L. Brotherton et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2008)
Seroreactivity to cutaneous human papillomaviruses among patients with nonmelanoma skin cancer or benign skin lesions
Kristin Andersson et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Clinical and immunologic results of a phase II trial of sequential imiquimod and photodynamic therapy for vulval intraepithelial neoplasia
Ursula Winters et al.
CLINICAL CANCER RESEARCH (2008)
TLR7 stimulation augments T effector-mediated rejection, of skin expressing neo-self antigen in keratinocytes
Jie Zhong et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Impact of vaccination with Cervarix™ on subsequent HPV-16/18 infection and cervical disease in women 15-25 years of age
Diane M. Harper
GYNECOLOGIC ONCOLOGY (2008)
Evolution of type-specific immunoassays to evaluate the functional immune response to Gardasil®
Judith F. Smith et al.
HUMAN VACCINES (2008)
IL-33 amplifies both Th1-and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK Cells
Molly D. Smithgall et al.
INTERNATIONAL IMMUNOLOGY (2008)
Skin reactions to human papillomavirus (HPV) 16 specific antigens intradermally injected in healthy subjects and patients with cervical neoplasia
Muriel van den Hende et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Cutaneous human papillomavirus infection, the EVER2 gene and incidence of squamous cell carcinoma:: A case-control study
Anita S. Patel et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Betapapillomaviruses: Innocent bystanders or causes of skin cancer
Mariet C. W. Feltkamp et al.
JOURNAL OF CLINICAL VIROLOGY (2008)
Detection of human papillomavirus DNA in cutaneous squamous cell carcinoma among immunocompetent individuals
Maryam M. Asgari et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Mechanisms of human papillomavirus type 16 neutralization by L2 cross-neutralizing and L1 type-specific antibodies
Patricia M. Day et al.
JOURNAL OF VIROLOGY (2008)
Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study
Margaret R. E. McCredie et al.
LANCET ONCOLOGY (2008)
Evolving immunosuppressive microenvironment during human cervical carcinogenesis
A. Kobayashi et al.
MUCOSAL IMMUNOLOGY (2008)
Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
Stephanie C. Eisenbarth et al.
NATURE (2008)
Natural History of Human Papillomavirus Infections, Cytologic and Histologic Abnormalities, and Cancer
Cosette Marie Wheeler
OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA (2008)
Clathrin- and Caveolin-Independent Entry of Human Papillomavirus Type 16-Involvement of Tetraspanin-Enriched Microdomains (TEMs)
Gilles Spoden et al.
PLOS ONE (2008)
Epidemiology and Natural History of Human Papillomavirus Infections and Type-Specific Implications in Cervical Neoplasia
F. Xavier Bosch et al.
VACCINE (2008)
HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine
Elmar A. Joura et al.
VACCINE (2008)
Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: Final report
David Yiu-Kuen But et al.
VACCINE (2008)
Epidemiology of Human Papillomavirus Infection in Men, Cancers other than Cervical and Benign Conditions
Anna R. Giuliano et al.
VACCINE (2008)
Seroprevalence of 34 human papillomavirus types in the German general population
Kristina M. Michael et al.
PLOS PATHOGENS (2008)
Human papillomavirus type 16 and 18 E7-pulsed dendritic cell vaccination of stage IB or IIA cervical cancer patients: A phase I escalating-dose trial
Alessandro D. Santin et al.
JOURNAL OF VIROLOGY (2008)
Hypersensitivity reactions to human papillomavirus vaccine in Australian schoolgirls: retrospective cohort study
Liew Woei Kang et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Vaccination trial with HPV16 L1E7 chimeric virus-like particles in women suffering from high grade cervical intraepithelial neoplasia (UN 2/3)
Andreas M. Kaufmann et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Adaptive immunity maintains occult cancer in an equilibrium state
Catherine M. Koebel et al.
NATURE (2007)
CD4+CD25hi regulatory T-cell frequency correlates with persistence of human papillomavirus type 16 and T helper cell responses in patients with cervical intraepithelial neoplasia
Johan W. Molling et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Human papillomavirus and cervical cancer
Mark Schiffman et al.
LANCET (2007)
A phase II study of Hsp-7 (SGN-00101) in women with high-grade cervical intraepithelial neoplasia
L. D. Roman et al.
GYNECOLOGIC ONCOLOGY (2007)
Human papillomavirus type 31 uses a caveolin 1-and dynamin 2-mediated entry pathway for infection of human keratinocytes
Jessica L. Smith et al.
JOURNAL OF VIROLOGY (2007)
Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection - A randomized trial
Allan Hildesheim et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Neutralization of human papillomavirus with monoclonal antibodies reveals different mechanisms of inhibition
Patricia M. Day et al.
JOURNAL OF VIROLOGY (2007)
Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine
Sven-Eric Olsson et al.
VACCINE (2007)
Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ:: a combined analysis of four randomised clinical trials
L. Villa et al.
LANCET (2007)
Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials
Elmar A. Joura et al.
LANCET (2007)
Betapapillomaviruses frequently persist in the skin of healthy individuals
Maurits N. C. de Koning et al.
JOURNAL OF GENERAL VIROLOGY (2007)
The epidemiology of human papillomavirus infection and cervical cancer
F. Xavier Bosch et al.
DISEASE MARKERS (2007)
MVA E2 recombinant vaccine in the treatment of human papillomavirus infection in men presenting intraurethral flat condyloma - A phase I/II study
Antonio Albarran y Carvajal et al.
BIODRUGS (2007)
Heat shock fusion protein-based immunotherapy for treatment of cervical intraepithelial neoplasia III
Mark H. Einstein et al.
GYNECOLOGIC ONCOLOGY (2007)
High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up
L. L. Villa et al.
BRITISH JOURNAL OF CANCER (2006)
Cell-mediated immune responses to COPV early proteins
Suchitra Jain et al.
VIROLOGY (2006)
Vaccination of healthy volunteers with human papillomavirus type 16 L2E7E6 fusion protein induces serum antibody that neutralizes across papillomavirus species
Ratish Gambhira et al.
CANCER RESEARCH (2006)
Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatus
Jill E. Koshiol et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells
Timothy D. Culp et al.
JOURNAL OF VIROLOGY (2006)
Overcoming original antigenic sin to generate new CD8 T cell IFN-γ responses in an antigen-experienced host
Xiao Song Liu et al.
JOURNAL OF IMMUNOLOGY (2006)
Mast cells are essential intermediaries in regulatory T-cell tolerance
Li-Fan Lu et al.
NATURE (2006)
Prophylactic HPV vaccines: Underlying mechanisms
Margaret Stanley et al.
VACCINE (2006)
Identification of type-specific and cross-reactive neutralizing conformational epitopes on the major capsid protein of human papillomavirus type 31
M. J. J. Fleury et al.
ARCHIVES OF VIROLOGY (2006)
Immunohistochemical analysis of CD4+ and CD8+ T-cell subsets in high risk human papillomavirus-associated pre-malignant and malignant lesions of the uterine cervix
Sylvain Monnier-Benoit et al.
GYNECOLOGIC ONCOLOGY (2006)
The global health burden of infection -associated cancers in the year 2002
Donald Maxwell Parkin
INTERNATIONAL JOURNAL OF CANCER (2006)
Regression of papilloma high-grade lesions (CIN 2 and CIN 3) is stimulated by therapeutic vaccination with MVA E2 recombinant vaccine
E. Garcia-Hernandez et al.
CANCER GENE THERAPY (2006)
A trial of SGN-00101 (HspE7) to treat high-grade anal intraepithelial neoplasia in HIV-positive individuals
Joel M. Palefsky et al.
AIDS (2006)
Prime-boost vaccination strategy in women with high-grade, noncervical anogenital intraepithelial neoplasia: clinical results from a multicenter phase II trial
AN Fiander et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2006)
Identification of human papillomavirus type 16 L1 surface loops required for neutralization by human sera
Joseph J. Carter et al.
JOURNAL OF VIROLOGY (2006)
Sustained efficacy up to 4-5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial
DM Harper et al.
LANCET (2006)
Results of the first WHO international collaborative study on the standardization of the detection of antibodies to human papillomaviruses
M Ferguson et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities
AD Santin et al.
GYNECOLOGIC ONCOLOGY (2006)
Detection of human papillomavirus type 18 E6 and E7-specific CD4+T-helper 1 immunity in relation to health versus disease
MJP Welters et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Naturally processed and HLA-B8-presented HPV16 E7 epitope recognized by T cells from patients with cervical cancer
S Oerke et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Cross-typic specificity and immunotherapeutic potential of a human HPV16 E7-specific CTL line
SJ Youde et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Epitope specificity and longevity of a vaccine-induced human T cell response against HPV18
KL Smith et al.
INTERNATIONAL IMMUNOLOGY (2005)
E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I
GH Ashrafi et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Therapeutic vaccination with MVA E2 can eliminate precancerous lesions (CIN 1, CIN 2, and CIN 3) associated with infection by oncogenic human papillomavirus
CMC Gutierrez et al.
HUMAN GENE THERAPY (2004)
Mutations in TAP genes are common in cervical carcinomas
NL Fowler et al.
GYNECOLOGIC ONCOLOGY (2004)
ZYC101a for treatment of high-grade cervical intralepithelial neoplasia: A randomized controlled trial
F Garcia et al.
OBSTETRICS AND GYNECOLOGY (2004)
Human papillomavirus type 16-positive cervical cancer is associated with impaired CD4+T-cell immunity against early antigens E2 and E6
A de Jong et al.
CANCER RESEARCH (2004)
Effect of TA-CIN (HPV 16 L2E6E7) booster immunisation in vulval intraepithelial neoplasia patients previously vaccinated with TA-HPV (vaccinia virus encoding HPV 16/18 E6E7)
EJ Davidson et al.
VACCINE (2004)
Human growth hormone presented by K14hGH-transgenic skin grafts induces a strong immune response but no graft rejection
J Zhong et al.
IMMUNOLOGY AND CELL BIOLOGY (2004)
Prevention of cervical cancer through papillomavirus vaccination
IH Frazer
NATURE REVIEWS IMMUNOLOGY (2004)
Phase I/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein-based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasia
S Hallez et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX™ adjuvant in women with cervical intraepithelial neoplasia
IH Frazer et al.
VACCINE (2004)
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial
DM Harper et al.
LANCET (2004)
Impaired antigen presentation and effectiveness of combined active/passive immunotherapy for epithelial tumors
K Matsumoto et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Immunological responses in women with human papillomavirus type 16 (HPV-16)-associated anogenital intraepithelial neoplasia induced by heterologous prime-boost HPV-16 oncogene vaccination
LJC Smyth et al.
CLINICAL CANCER RESEARCH (2004)
Dendritic cell-based tumor vaccine for cervical cancer II:: results of a clinical pilot study in 15 individual patients
A Ferrara et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2003)
Immunotherapy of human cervical high-grade cervical intraepithelial neoplasia with microparticle-delivered human papillomavirus 16 E7 plasmid DNA
EE Sheets et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2003)
Human papillomavirus types 16, 31, and 58 use different endocytosis pathways to enter cells
L Bousarghin et al.
JOURNAL OF VIROLOGY (2003)
Papillomaviruses infect cells via a clathrin-dependent pathway
PM Day et al.
VIROLOGY (2003)
Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis
N Ramoz et al.
NATURE GENETICS (2002)
Childhood indicators of susceptibility to subsequent cervical cancer
SM Montgomery et al.
BRITISH JOURNAL OF CANCER (2002)
Enhancement of human papillomavirus (HPV) type 16 E6 and E7-specific T-cell immunity in healthy volunteers through vaccination with TA-CIN, an HPV16 L2E7E6 fusion protein vaccine
A de Jong et al.
VACCINE (2002)
Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses
AL Combita et al.
JOURNAL OF VIROLOGY (2002)
Activity of HspE7, a novel immunotherapy, in patients with anogenital warts
SE Goldstone et al.
DISEASES OF THE COLON & RECTUM (2002)
Antigen processing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomavirus 16 E6
M Evans et al.
JOURNAL OF IMMUNOLOGY (2001)
Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-κB-responsive genes in cervical keratinocytes
M Nees et al.
JOURNAL OF VIROLOGY (2001)
Papillomavirus capsid protein expression in Escherichia coli:: Purification and assembly of HPV11 and HPV16 L1
XJS Chen et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)
Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia
LL Villa et al.
JOURNAL OF GENERAL VIROLOGY (2000)
The human papillomavirus E7 protein is able to inhibit the antiviral and anti-growth functions of interferon-α
P Barnard et al.
VIROLOGY (2000)
Papillomavirus virus-like particles for the delivery of multiple cytotoxic T cell epitopes
WJ Liu et al.
VIROLOGY (2000)
Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein - Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis
JS Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16
XJS Chen et al.
MOLECULAR CELL (2000)
Type specificity and significance of different isotypes of serum antibodies to human papillomavirus capsids
ZH Wang et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
分享论文
